Lupin is a global pharmaceutical company committed to catalyzing treatments that transform hope into healing through sustainable healthcare solutions. The company addresses environmental and social challenges while maintaining focus on environmental responsibility and social impact. Lupin has achieved an S&P Global ESG Score of 91 for 2025 and secured inclusion in the S&P Global Sustainability Yearbook 2025 for the second consecutive year.
About Lupin Limited
- Status
- Unverified
- Website
- Visit Website
Lupin Limited Sustainability Actions
Lupin Limited Sustainability Commitments
2025
S&P Global Sustainability Yearbook inclusion
Lupin secured inclusion in the S&P Global Sustainability Yearbook 2025 for the second consecutive year, demonstrating ongoing commitment to sustainability standards.
2024
Sustainable business partner requirements
Lupin requires all business partners to comply with essential sustainability criteria, including labor rights, health and safety standards, and environmental compliance.